Press Releases

Press Releases

January 2 | 2019
SOUTH SAN FRANCISCO, Calif.--( BUSINESS WIRE )--FLX Bio, Inc., a clinical-stage, biopharmaceutical company focused on the development of oral small-molecule drugs that target immune drivers of cancer and other immune-related disorders, today announced that Brian Wong, M.D., Ph.D., CEO will present
Displaying 11 - 11 of 11